Series |
1 Senior Research Fellow, Department of Primary Care and Population Sciences,
University College London, Holborn Union Building, Highgate Hill, London N19
5LW;
2 Lecturer, School of Health Sciences and Social Care, Brunel University,
Osterley Campus, Borough Road, Middlesex TW7 5DU, UK
E-mail: s.shaw{at}pcps.ucl.ac.uk
SUMMARY
Risk assessment can be thought of as the lens through which we anticipate the consequences of research and the impact of the actions of researchers. The way in which risk of harm is managed in research is strongly influenced by the surrounding social and political environment, leading to differences in national and local styles of regulation and review.
Different research studies carry different risks, so systems for review and approval must adapt to the question being asked and the nature of the study. Researchers can never wholly guarantee safety in any research but participants and researchers must be offered reasonable protection within any study, with appropriate arrangements in place should something go wrong.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
L. Brown, M. Parker, and M. Dixon-Woods Whose interest? British newspaper reporting of use of medical records for research J Health Serv Res Policy, July 1, 2008; 13(3): 140 - 145. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kielmann, A. Tierney, R. Porteous, G. Huby, A. Sheikh, and H. Pinnock The Department of Health's research governance framework remains an impediment to multi-centre studies: findings from a national descriptive study J R Soc Med, May 1, 2007; 100(5): 234 - 238. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A.-S. Salman, T. M Brock, M. S Dennis, P. A G Sandercock, P. M White, and C. Warlow Research governance impediments to clinical trials: a retrospective survey J R Soc Med, February 1, 2007; 100(2): 101 - 104. [Abstract] [Full Text] [PDF] |
||||